Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07537712) titled 'Proton vs Photon IMRT Toxicity in Breast Cancer' on April 6.
Study Type: Observational
Primary Sponsor: Ruijin Hospital
Condition:
Breast Cancer
Intervention:
Radiation: Intensity-modulated photon radiotherapy (IMRT/VMAT)
Recruitment Status: Not recruiting
Date of First Enrollment: April 2026
Target Sample Size: 750
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07537712
Disclaimer: Curated by HT Syndication....